Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs AUROBINDO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA AUROBINDO PHARMA AJANTA PHARMA/
AUROBINDO PHARMA
 
P/E (TTM) x 23.7 12.9 183.0% View Chart
P/BV x 4.9 1.1 436.5% View Chart
Dividend Yield % 0.8 1.9 39.8%  

Financials

 AJANTA PHARMA   AUROBINDO PHARMA
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-22
AUROBINDO PHARMA
Mar-22
AJANTA PHARMA/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs1,6141,064 151.7%   
Low Rs1,089584 186.3%   
Sales per share (Unadj.) Rs391.1400.3 97.7%  
Earnings per share (Unadj.) Rs83.445.7 182.5%  
Cash flow per share (Unadj.) Rs98.164.9 151.1%  
Dividends per share (Unadj.) Rs9.509.00 105.6%  
Avg Dividend yield %0.71.1 64.4%  
Book value per share (Unadj.) Rs382.1419.4 91.1%  
Shares outstanding (eoy) m85.42585.94 14.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.52.1 167.9%   
Avg P/E ratio x16.218.0 89.9%  
P/CF ratio (eoy) x13.812.7 108.6%  
Price / Book Value ratio x3.52.0 180.0%  
Dividend payout %11.419.7 57.8%   
Avg Mkt Cap Rs m115,433482,799 23.9%   
No. of employees `000NANA-   
Total wages/salary Rs m6,45834,509 18.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m33,410234,555 14.2%  
Other income Rs m1,1573,226 35.9%   
Total revenues Rs m34,567237,781 14.5%   
Gross profit Rs m9,29342,566 21.8%  
Depreciation Rs m1,25311,265 11.1%   
Interest Rs m102486 21.0%   
Profit before tax Rs m9,09534,040 26.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,9687,256 27.1%   
Profit after tax Rs m7,12726,784 26.6%  
Gross profit margin %27.818.1 153.3%  
Effective tax rate %21.621.3 101.5%   
Net profit margin %21.311.4 186.8%  
BALANCE SHEET DATA
Current assets Rs m24,548181,227 13.5%   
Current liabilities Rs m8,37781,560 10.3%   
Net working cap to sales %48.442.5 113.9%  
Current ratio x2.92.2 131.9%  
Inventory Days Days4225 167.0%  
Debtors Days Days1162 17.8%  
Net fixed assets Rs m19,259155,104 12.4%   
Share capital Rs m172586 29.3%   
"Free" reserves Rs m32,469245,174 13.2%   
Net worth Rs m32,640245,760 13.3%   
Long term debt Rs m162,492 0.7%   
Total assets Rs m43,807336,331 13.0%  
Interest coverage x90.271.0 127.0%   
Debt to equity ratio x00 5.0%  
Sales to assets ratio x0.80.7 109.4%   
Return on assets %16.58.1 203.5%  
Return on equity %21.810.9 200.3%  
Return on capital %28.213.9 202.5%  
Exports to sales %031.1 0.0%   
Imports to sales %011.9 0.0%   
Exports (fob) Rs mNA72,862 0.0%   
Imports (cif) Rs mNA27,965 0.0%   
Fx inflow Rs m18,67877,245 24.2%   
Fx outflow Rs m3,66231,524 11.6%   
Net fx Rs m15,01645,721 32.8%   
CASH FLOW
From Operations Rs m5,62050,165 11.2%  
From Investments Rs m-741-32,116 2.3%  
From Financial Activity Rs m-4,600-29,693 15.5%  
Net Cashflow Rs m279-11,674 -2.4%  

Share Holding

Indian Promoters % 70.5 48.8 144.5%  
Foreign collaborators % 0.0 3.1 -  
Indian inst/Mut Fund % 21.4 38.0 56.3%  
FIIs % 8.2 21.4 38.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.5 48.2 61.3%  
Shareholders   62,048 358,459 17.3%  
Pledged promoter(s) holding % 17.4 15.9 109.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    ZYDUS LIFESCIENCES    


More on AJANTA PHARMA vs Aurobindo Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

AJANTA PHARMA vs Aurobindo Pharma Share Price Performance

Period AJANTA PHARMA Aurobindo Pharma S&P BSE HEALTHCARE
1-Day 0.48% 0.12% -0.51%
1-Month -7.57% -15.77% -2.40%
1-Year -11.94% -30.29% -6.01%
3-Year CAGR 23.51% 1.41% 20.80%
5-Year CAGR 6.90% -6.98% 11.38%

* Compound Annual Growth Rate

Here are more details on the AJANTA PHARMA share price and the Aurobindo Pharma share price.

Moving on to shareholding structures...

The promoters of AJANTA PHARMA hold a 70.5% stake in the company. In case of Aurobindo Pharma the stake stands at 51.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of AJANTA PHARMA and the shareholding pattern of Aurobindo Pharma.

Finally, a word on dividends...

In the most recent financial year, AJANTA PHARMA paid a dividend of Rs 9.5 per share. This amounted to a Dividend Payout ratio of 11.4%.

Aurobindo Pharma paid Rs 9.0, and its dividend payout ratio stood at 19.7%.

You may visit here to review the dividend history of AJANTA PHARMA, and the dividend history of Aurobindo Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Tanks 320 Points| PolicyBazaar Stake Sale| Oil & Gas and Auto Stocks Witness Most Selling(10:30 am)

Indian share markets opened on a negative note today halting their eight-day rally, amid a weak trend in global markets.